Also known as: (R)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine
Atomoxetine is a highly selective and potent inhibitor of the pre-synaptic noradrenaline transporter, its presumed mechanism of action, without directly affecting the serotonin or dopamine transporters.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Atomoxetine is the active ingredient of these drugs:
Australia Austria Canada Cyprus Finland
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):